BidaskScore Reports Redhill Biopharma (RDHL) Upgrade; Price T Rowe Associates Cut Dicks Sporting Goods (DKS) Position By $7.73 Million

Dick's Sporting Goods, Inc. (NYSE:DKS) Logo

Price T Rowe Associates Inc decreased Dicks Sporting Goods Inc (DKS) stake by 83.96% reported in 2018Q4 SEC filing. Price T Rowe Associates Inc sold 249,308 shares as Dicks Sporting Goods Inc (DKS)’s stock rose 2.23%. The Price T Rowe Associates Inc holds 47,636 shares with $1.49M value, down from 296,944 last quarter. Dicks Sporting Goods Inc now has $3.35B valuation. The stock decreased 2.66% or $0.93 during the last trading session, reaching $34.05. About 3.17M shares traded or 44.94% up from the average. Dick's Sporting Goods, Inc. (NYSE:DKS) has risen 18.37% since March 17, 2018 and is uptrending. It has outperformed by 14.00% the S&P500. Some Historical DKS News: 09/03/2018 – Dick’s Sporting Closes Above 200-Day Moving Average; 30/05/2018 – DICK’S: GUN POLICY WILL HURT HUNTING BUSINESS FOR REST OF YEAR; 13/03/2018 – DICK’S SPORTING 4Q ADJ EPS $1.22, EST. $1.24; 30/05/2018 – Dick’s Sporting Goods 1Q Adj EPS 52c; 13/03/2018 – DICK’S SPORTING 4Q EPS $1.11; 14/03/2018 – Sen. Feinsten: Feinstein Hosts Dick’s Sporting Goods CEO Ed Stack; 13/03/2018 – Dick’s Sporting Goods 4Q EPS $1.11; 30/05/2018 – DICK’S SPORTING GOODS- FOR 2018 SEES CONSOLIDATED SAME STORE SALES BETWEEN ABOUT FLAT TO LOW SINGLE-DIGIT FALL ON 52-WEEK TO 52-WEEK COMPARATIVE BASIS; 06/03/2018 – Orvis Follows Walmart and Dick’s in Raising Age for Gun Sales; 10/04/2018 – DICK’S Sporting Goods Announces Grand Opening of Two New Stores in April

New York-listed Redhill Biopharma (NASDAQ:RDHL), was upped by stock research analysts at BidaskScore. BidaskScore upped its rating on the $247.03M market cap company to a Hold.

Price T Rowe Associates Inc increased Simply Good Foods Co stake by 1.26M shares to 8.03 million valued at $151.68M in 2018Q4. It also upped V F Corp (NYSE:VFC) stake by 9,160 shares and now owns 578,240 shares. Cimarex Energy Co (NYSE:XEC) was raised too.

More notable recent Dick's Sporting Goods, Inc. (NYSE:DKS) news were published by: which released: “Dick’s Sporting Goods Couldn’t Get Over the Hump in 2018 – Nasdaq” on March 17, 2019, also with their article: “5 Top Stock Trades for Wednesday: SFIX, COUP, MOMO, DKS – Yahoo Finance” published on March 12, 2019, published: “Stock Market Today: Stitch Fix Soars on Stellar Earnings – The Motley Fool” on March 12, 2019. More interesting news about Dick's Sporting Goods, Inc. (NYSE:DKS) were released by: and their article: “AT&T Bets On Diversity – Barron’s” published on March 16, 2019 as well as‘s news article titled: “Mid-Morning Market Update: Markets Mixed; Dicks Sporting Goods Profit Tops Views – Nasdaq” with publication date: March 12, 2019.

Investors sentiment decreased to 0.81 in Q4 2018. Its down 0.33, from 1.14 in 2018Q3. It fall, as 46 investors sold DKS shares while 107 reduced holdings. 52 funds opened positions while 72 raised stakes. 75.28 million shares or 2.59% more from 73.38 million shares in 2018Q3 were reported. Spark Invest Mgmt Limited Liability Corporation holds 0.67% or 310,400 shares. Tci Wealth Advsrs Inc reported 20 shares. Sit Invest Assocs owns 0% invested in Dick's Sporting Goods, Inc. (NYSE:DKS) for 4,450 shares. Tower Rech Limited Liability (Trc) holds 0.01% in Dick's Sporting Goods, Inc. (NYSE:DKS) or 6,673 shares. Edgestream Partners Limited Partnership has invested 0.18% in Dick's Sporting Goods, Inc. (NYSE:DKS). Landscape Capital Ltd Liability Co invested 0.03% in Dick's Sporting Goods, Inc. (NYSE:DKS). State Board Of Administration Of Florida Retirement Systems invested 0.01% in Dick's Sporting Goods, Inc. (NYSE:DKS). Bancshares Of America Corp De invested in 0% or 329,345 shares. Engineers Gate Manager Lp reported 80,939 shares. Phoenix Adviser Limited Company invested in 0.58% or 8,800 shares. Millennium Mngmt Limited Liability Corp stated it has 0% of its portfolio in Dick's Sporting Goods, Inc. (NYSE:DKS). Acadian Asset Mngmt Llc invested in 0% or 2,839 shares. Zuckerman Inv Gp Limited Liability invested in 2.22% or 256,444 shares. Gargoyle Inv Advisor Limited Liability owns 45,001 shares for 1.28% of their portfolio. Rwwm reported 6.32% of its portfolio in Dick's Sporting Goods, Inc. (NYSE:DKS).

Among 10 analysts covering Dick’s Sporting Goods (NYSE:DKS), 2 have Buy rating, 0 Sell and 8 Hold. Therefore 20% are positive. Dick’s Sporting Goods had 16 analyst reports since October 11, 2018 according to SRatingsIntel. The stock has “Buy” rating by Susquehanna on Wednesday, March 13. The stock has “Buy” rating by Argus Research on Tuesday, December 11. The stock of Dick's Sporting Goods, Inc. (NYSE:DKS) has “Hold” rating given on Tuesday, March 12 by RBC Capital Markets. The firm has “Buy” rating by Susquehanna given on Sunday, November 25. The rating was maintained by Susquehanna on Wednesday, March 6 with “Buy”. Canaccord Genuity maintained the shares of DKS in report on Wednesday, March 13 with “Hold” rating. J.P. Morgan downgraded Dick's Sporting Goods, Inc. (NYSE:DKS) rating on Thursday, November 29. J.P. Morgan has “Hold” rating and $4100 target. As per Thursday, October 11, the company rating was maintained by Morgan Stanley. The firm has “Neutral” rating given on Thursday, November 29 by JP Morgan. The stock has “Neutral” rating by Citigroup on Monday, December 3.

Analysts await RedHill Biopharma Ltd. (NASDAQ:RDHL) to report earnings on May, 14. They expect $-0.39 earnings per share, up 22.00% or $0.11 from last year’s $-0.5 per share. After $-0.34 actual earnings per share reported by RedHill Biopharma Ltd. for the previous quarter, Wall Street now forecasts 14.71% negative EPS growth.

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases, and cancer. The company has market cap of $247.03 million. The firm promotes two gastrointestinal products in the U.S., such as Donnatal, a prescription oral adjunctive drug used in the treatment of IBS and acute enterocolitis; and EnteraGam, a medical food intended for the dietary management under medical supervision of chronic diarrhea and loose stools. It currently has negative earnings. The Company’s clinical-stage pipeline includes TALICIA , an oral combination therapy for the treatment of Helicobacter pylori infection with successful results from a first Phase III study and an ongoing confirmatory Phase III study; RHB-104, an oral combination therapy for the treatment of Crohn's disease with an ongoing first Phase III study, a completed proof-of-concept Phase IIa study for multiple sclerosis, and QIDP status for nontuberculous mycobacteria infections; BEKINDA (RHB-102), a once-daily oral pill formulation of ondansetron with successful top-line results in a Phase III study for acute gastroenteritis and gastritis and an ongoing Phase II study for IBS-D; RHB-106, an encapsulated bowel preparation licensed to Salix Pharmaceuticals, Ltd.; YELIVA (ABC294640), a Phase II-stage, orally-administered, first-in-class SK2 selective inhibitor targeting multiple oncology, inflammatory, and gastrointestinal indications; MESUPRON, a Phase II-stage first-in-class, orally-administered protease inhibitor, targeting pancreatic cancer and other solid tumors; and RIZAPORT (RHB-103), an oral thin film formulation of rizatriptan for acute migraines, with a U.S.

Among 2 analysts covering RedHill Biopharma (NASDAQ:RDHL), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. RedHill Biopharma has $17 highest and $16 lowest target. $16.50’s average target is 92.98% above currents $8.55 stock price. RedHill Biopharma had 2 analyst reports since February 27, 2019 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, February 27 by H.C. Wainwright. The rating was upgraded by WBB Securities on Tuesday, March 12 to “Buy”.

More notable recent RedHill Biopharma Ltd. (NASDAQ:RDHL) news were published by: which released: “RedHill Biopharma to Present at the 31st Annual ROTH Conference – Nasdaq” on March 11, 2019, also with their article: “RedHill Biopharma Provides Full-Year 2018 Financial Results and Operational Highlights – Nasdaq” published on February 26, 2019, published: “RedHill Biopharma to Present at the 8th Annual SVB Leerink Healthcare Conference – Nasdaq” on February 19, 2019. More interesting news about RedHill Biopharma Ltd. (NASDAQ:RDHL) were released by: and their article: “RedHill Biopharma Strengthens Management Team with Appointment of Rick D. Scruggs as Chief Operating Officer, US Operations – Nasdaq” published on February 20, 2019 as well as‘s news article titled: “RedHill Biopharma Announces New European and Japanese Patents for Talicia – Nasdaq” with publication date: March 04, 2019.

Dick's Sporting Goods, Inc. (NYSE:DKS) Institutional Positions Chart